Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00311350
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2006-04-03
Brief Title:
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
Sponsor:
Bausch Health Americas Inc
Organization:
Bausch Health Americas Inc
Study Overview
Official Title:
Ascending Multiple Dose Study of the Safety Tolerability and Pharmacokinetics of MOA-728 Administered Orally to Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is the first multiple-dose experience in humans with MOA-728 in an oral formulation This study will provide an assessment of the safety tolerability and pharmacokinetics PK of MOA-728 following administration of ascending multiple oral doses to healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None